Review of biologics, biosimilars, and intended copies in rheumatology, and current practice in Iraq

Biologic therapies are an important option in the treatment of patients with rheumatic disease. As the development of potential biosimilars increases, many countries are following the guidelines developed by the WHO, European Medicines Agency, or US Food and Drug Administration to create country-spe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Access Rheumatol
Main Authors: Al Ani, Nizar Abdulateef, Gorial, Faiq I, Al-Sulaitti, Saad, Humadi, Jasmine Abbas, Awadh, Nabaa Ihsan, Mounir, Mohamed, Dershaby, Yasser El, Jones, Heather, Sunna, Nancy
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2018
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6307490/
https://ncbi.nlm.nih.gov/pubmed/30613169
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OARRR.S176965
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados